GS vs SNTI · P/E 20, rev $37.56B vs rev $33.0K
Goldman Sachs Group Inc (GS) versus Senti Biosciences Inc (SNTI) — a side-by-side from cached financials, not a winner call.
Goldman Sachs Group Inc (GS) is a capital markets company listed on NYSE. It is led by David Solomon.
Senti Biosciences Inc (SNTI) is a biotechnology company listed on NASDAQ.
Latest reported GS revenue for 2026-06-30 was $37.56B. Net income was $12.26B. GS currently screens at market cap $324.25B and trailing P/E 20.1.
Latest reported SNTI revenue for 2026-06-30 was $33.0K. Net income was -$17.0M. SNTI currently screens at market cap $29.6M.
GS currently screens at market cap $324.25B and trailing P/E 20.1. SNTI currently screens at market cap $29.6M.
Not investment advice. Open the GS and SNTI stock pages for the full models.
Not investment advice.